Researchers have discovered that a protein called cardiotrophin 1 (CT1) can trick the heart into growing in a healthy way and pumping more blood, just as it does in response to exercise and pregnancy. They show that this good kind of heart growth is very different from the harmful enlargement of the heart that occurs during heart failure. They also show that CT1 can repair heart damage and improve blood flow in animal models of heart failure.
The results are published in Cell Research. The research team is from The Ottawa Hospital, the University of Ottawa, the University of Ottawa Heart Institute and Carleton University.
Heart failure is a leading cause of death and disability in high-income countries and a growing problem around the world. It occurs when the heart can’t pump enough blood through the body, often because a heart attack has damaged the heart muscle tissue.
“When part of the heart dies, the remaining muscles try to adapt by getting bigger, but this happens in a dysfunctional way and it doesn’t actually help the heart pump more blood,” said Dr. Lynn Megeney, senior author of the study and a senior scientist at The Ottawa Hospital and professor at the University of Ottawa. “We found that CT1 causes heart muscles to grow in a more healthy way and it also stimulates blood vessel growth in the heart. This actually increases the heart’s ability to pump blood, just like what you would see with exercise and pregnancy.”
Dr. Megeney and his colleagues conducted a variety of studies in mice, rats and cells growing in the lab. In addition to CT-1, some of the studies involved a drug called phenylephrine (PE), which is known to cause the bad kind of heart growth. They found:
• Heart muscle cells treated with CT-1 become longer, healthier fibres, while those treated with PE just grow wider.
• CT-1 causes blood vessels to grow alongside the new heart muscle tissue and increases the heart’s ability to pump blood, while PE does neither.
• When CT-1 treatment stops, the heart goes back to its original condition, just like it does when exercise or pregnancy end. However, the dysfunctional heart growth caused by PE is irreversible.
• CT-1 dramatically improves heart function in two animal models of heart failure – one caused by a heart attack (affecting the left side of the heart) and one caused by high blood pressure in the lungs (pulmonary hypertension, affecting the right side of the heart).
• Both CT-1 and PE stimulate heart muscle growth through a molecular pathway that has traditionally been associated with promoting cell suicide (apoptosis), but CT-1 has a better ability to control this pathway.
“This experimental therapy is very exciting, particularly because it shows promise in treating both left and right heart failure,” said Dr. Duncan Stewart, a cardiologist, senior scientist and co-senior author on the paper who is also Executive Vice-President of Research at The Ottawa Hospital and a professor at the University of Ottawa. “Currently, the only treatment for right heart failure is a transplant. And although we have drugs that can reduce the symptoms of left heart failure, we can’t fix the problem, and left heart failure often leads to right heart failure over time.”
“An intriguing aspect of this research was how human CT1 was able to promote a healthy growth response in multiple animal models,” said co-author Dr. Patrick Burgon, scientist at the University of Ottawa Heart Institute and assistant professor at the University of Ottawa. “This suggests the action of CT1 is universally conserved and puts us much closer to therapy.”
The researchers also note that while exercise could theoretically have the same benefits as CT-1, people with heart failure are usually limited in their ability to exercise.
Dr. Megeney and Dr. Stewart have patents pending for the use of CT-1 to treat heart conditions and they hope to develop partnerships to test this protein in patients. If this testing is successful it will take a number of years for the treatment to become widely available.
The Latest on: Heart failure
[google_news title=”” keyword=”heart failure” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Study: Women with heart disease prescribed cholesterol-lowering drugs less often than menon April 25, 2024 at 3:36 am
Women with heart disease may be prescribed cholesterol-reducing statins less frequently than men, in contravention of recommended treatment guidelines, according to new research released Thursday.
- Women with heart disease are less likely to receive life-saving drugs than men, researchers findon April 25, 2024 at 3:10 am
Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European ...
- Report: Heart failure death rate climbs, perhaps as a result of pandemicon April 24, 2024 at 11:46 pm
Reports on heart failure mortality during the past several years show that it’s on the rise more recently compared to declines, but a research letter released Wednesday in JAMA Cardiology blames the ...
- Scientific Breakthrough Could Tackle Depression and Heart Diseaseon April 24, 2024 at 9:00 pm
Researchers have discovered a genetic link between depression and heart disease that could help to find new drugs to target both conditions. A team of scientists at Tampere University in Finland ...
- Heart failure mortalities increase — and moreon April 24, 2024 at 2:45 pm
Medical Watch Digest for April 24 A troubling trend when it comes to heart health. Patients and their doctors are failing when it comes to heart care. Heart failure rates are now on pace to wipe out ...
- Unveiling immune features of heart failure paves the way for targeted therapieson April 24, 2024 at 1:25 pm
In a recent study published in the Science Bulletin, researchers comprehensively examined the composition and phenotypic features of myeloid cells in human failing hearts at a single-cell level, ...
- Decline in heart failure deaths has been undone, led by people under 45on April 24, 2024 at 8:00 am
In heart failure, "the paradox is that at a time that we're seeing these increases in mortality, we also have access to better medications,” Mount Sinai Morningside's chief of cardiology said.
- Younger adults with atrial fibrillation face higher rates of heart failure and strokeon April 24, 2024 at 5:14 am
The risk factor (RF) burden, clinical outcomes, and long-term survival among patients with atrial fibrillation (AF) under 65 years of age.
- Women’s heart disease is under-diagnosed, but new scoring system could help solve this problemon April 23, 2024 at 12:42 am
Researchers are recommending utilizing big data and machine learning to improve the widely used Framingham Risk Score to better diagnose women with cardiovascular disease ...
- Study: Heart failure, not stroke, most common complication of atrial fibrillationon April 18, 2024 at 12:19 pm
Doctors tell patients with atrial fibrillation, which causes an irregular and often abnormally rapid heart rate, to beware of an increased risk of stroke. But the threat of heart failure should be ...
via Google News and Bing News